PURPOSE: The purpose of this study was to directly compare two isotopic metabolic imaging approaches, hyperpolarized (HP) 13 C MRI and deuterium metabolic imaging (DMI), for imaging specific closely related segments of cerebral glucose metabolism at 4.7 T. METHODS: Comparative HP-13 C and DMI neuroimaging experiments were conducted consecutively in normal rats during the same scanning session. Localized conversions of [1-13 C]pyruvate and [6,6-2 H2 ]glucose to their respective downstream metabolic products were measured by spectroscopic imaging, using an identical 2D-CSI sequence with parameters optimized for the respective experiments. To facilitate direct comparison, a pair of substantially equivalent 2.5-cm double-tuned X/1 H RF surface coils was developed. For improved results, multidimensional low-rank reconstruction was applied to denoise the raw DMI data. RESULTS: Localized conversion of HP [1-13 C]pyruvate to [1-13 C]lactate, and [6,6-2 H2 ]glucose to [3,3-2 H2 ]lactate and Glx-d (glutamate and glutamine), was detected in rat brain by spectroscopic imaging at 4.7 T. The SNR and spatial resolution of HP-13 C MRI was superior to DMI but limited to a short time window, whereas the lengthy DMI acquisition yielded maps of not only lactate, but also Glx production, albeit with relatively poor spectral discrimination between metabolites at this field strength. Across the individual rats, there was an apparent inverse correlation between cerebral production of HP [1-13 C]lactate and Glx-d, along with a trend toward increased [3,3-2 H2 ]lactate. CONCLUSION: The HP-13 C MRI and DMI methods are both feasible at 4.7 T and have significant potential for metabolic imaging of specific segments of glucose metabolism.
PURPOSE: The purpose of this study was to directly compare two isotopic metabolic imaging approaches, hyperpolarized (HP) 13 C MRI and deuterium metabolic imaging (DMI), for imaging specific closely related segments of cerebral glucose metabolism at 4.7 T. METHODS: Comparative HP-13 C and DMI neuroimaging experiments were conducted consecutively in normal rats during the same scanning session. Localized conversions of [1-13 C]pyruvate and [6,6-2 H2 ]glucose to their respective downstream metabolic products were measured by spectroscopic imaging, using an identical 2D-CSI sequence with parameters optimized for the respective experiments. To facilitate direct comparison, a pair of substantially equivalent 2.5-cm double-tuned X/1 H RF surface coils was developed. For improved results, multidimensional low-rank reconstruction was applied to denoise the raw DMI data. RESULTS: Localized conversion of HP [1-13 C]pyruvate to [1-13 C]lactate, and [6,6-2 H2 ]glucose to [3,3-2 H2 ]lactate and Glx-d (glutamate and glutamine), was detected in rat brain by spectroscopic imaging at 4.7 T. The SNR and spatial resolution of HP-13 C MRI was superior to DMI but limited to a short time window, whereas the lengthy DMI acquisition yielded maps of not only lactate, but also Glx production, albeit with relatively poor spectral discrimination between metabolites at this field strength. Across the individual rats, there was an apparent inverse correlation between cerebral production of HP [1-13 C]lactate and Glx-d, along with a trend toward increased [3,3-2 H2 ]lactate. CONCLUSION: The HP-13 C MRI and DMI methods are both feasible at 4.7 T and have significant potential for metabolic imaging of specific segments of glucose metabolism.
Authors: Hsin-Yu Chen; Adam W Autry; Jeffrey R Brender; Shun Kishimoto; Murali C Krishna; Maryam Vareth; Robert A Bok; Galen D Reed; Lucas Carvajal; Jeremy W Gordon; Mark van Criekinge; David E Korenchan; Albert P Chen; Duan Xu; Yan Li; Susan M Chang; John Kurhanewicz; Peder E Z Larson; Daniel B Vigneron Journal: Magn Reson Med Date: 2020-06-05 Impact factor: 4.668
Authors: Robin A de Graaf; Arjan D Hendriks; Dennis W J Klomp; Chathura Kumaragamage; Dimitri Welting; Catalina S Arteaga de Castro; Peter B Brown; Scott McIntyre; Terence W Nixon; Jeanine J Prompers; Henk M De Feyter Journal: NMR Biomed Date: 2019-12-26 Impact factor: 4.044
Authors: Jan H Ardenkjaer-Larsen; Björn Fridlund; Andreas Gram; Georg Hansson; Lennart Hansson; Mathilde H Lerche; Rolf Servin; Mikkel Thaning; Klaes Golman Journal: Proc Natl Acad Sci U S A Date: 2003-08-20 Impact factor: 11.205
Authors: R Gruetter; E J Novotny; S D Boulware; G F Mason; D L Rothman; G I Shulman; J W Prichard; R G Shulman Journal: J Neurochem Date: 1994-10 Impact factor: 5.372
Authors: Simon Hu; Peder E Z Larson; Mark Vancriekinge; Andrew M Leach; Ilwoo Park; Christine Leon; Jenny Zhou; Peter J Shin; Galen Reed; Paul Keselman; Cornelius von Morze; Hikari Yoshihara; Robert A Bok; Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron Journal: Magn Reson Imaging Date: 2012-10-27 Impact factor: 2.546
Authors: Jeremy W Gordon; Hsin-Yu Chen; Adam Autry; Ilwoo Park; Mark Van Criekinge; Daniele Mammoli; Eugene Milshteyn; Robert Bok; Duan Xu; Yan Li; Rahul Aggarwal; Susan Chang; James B Slater; Marcus Ferrone; Sarah Nelson; John Kurhanewicz; Peder E Z Larson; Daniel B Vigneron Journal: Magn Reson Med Date: 2018-10-30 Impact factor: 4.668
Authors: James T Grist; Mary A McLean; Frank Riemer; Rolf F Schulte; Surrin S Deen; Fulvio Zaccagna; Ramona Woitek; Charlie J Daniels; Joshua D Kaggie; Tomasz Matys; Ilse Patterson; Rhys Slough; Andrew B Gill; Anita Chhabra; Rose Eichenberger; Marie-Christine Laurent; Arnaud Comment; Jonathan H Gillard; Alasdair J Coles; Damian J Tyler; Ian Wilkinson; Bristi Basu; David J Lomas; Martin J Graves; Kevin M Brindle; Ferdia A Gallagher Journal: Neuroimage Date: 2019-01-11 Impact factor: 6.556
Authors: Ayhan Gursan; Martijn Froeling; Arjan D Hendriks; Dimitri Welting; Arno P M Kentgens; Dennis W J Klomp; Jeanine J Prompers Journal: Magn Reson Med Date: 2021-10-17 Impact factor: 3.737